stockrowAprea Therapeutics, Inc. (APRE) vs Cerenome, Inc. (CNSY)
- Aprea Therapeutics, Inc. APRE 0.43 −2.27%
- Cerenome, Inc. CNSY 1.09 +41.56%
Aprea Therapeutics, Inc. and Cerenome, Inc. are both Biotechnology companies. Aprea Therapeutics, Inc. and Cerenome, Inc. are of similar size ($6.3M and $5.9M). Cerenome, Inc. grew revenue faster over the last twelve months: −21.0% against −81.0%. Aprea Therapeutics, Inc. has the higher net margin (0.00% vs −620.7%) and the higher return on invested capital (0.00% vs −532.8%). Across the 15 metrics below, Aprea Therapeutics, Inc. leads on 11 and Cerenome, Inc. on 4.
Valuation
Profitability
| Metric | APRE | CNSY | Biotechnology median |
|---|---|---|---|
| Gross margin | 100.00% | 100.00% | 68.27% |
| Operating margin | 0.00% | (628.12%) | 0.00% |
| Net margin | 0.00% | (620.70%) | 0.00% |
| Free cash flow margin | 0.00% | (560.29%) | 0.00% |
| Return on equity | (62.83%) | (614.05%) | (50.82%) |
| Return on assets | (53.24%) | (214.01%) | (46.08%) |
| Return on invested capital | 0.00% | (532.77%) | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack